🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Retraining Reaching in Cerebellar Ataxia

RecruitingNAAges 22 Years - 80 YearsAllHugo W. Moser Research Institute at Kennedy Krieg…
NCT03879018 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to test for benefits of reinforcement based training paradigm versus standard practice over weeks for improving reaching movements in people with ataxia.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Cerebellar damage from stroke, tumor or degeneration * Age 22-80 Exclusion Criteria: * Clinical or MRI evidence of damage to extracerebellar brain (e.g. multiple system atrophy) * Extrapyramidal symptoms, peripheral vestibular loss, or sensory neuropathy * Dementia ( Mini-Mental State exam \> 22) * Pain that interferes with the tasks * Vision loss that interferes with the tasks
💊

What it tests

  • Reach training with visual feedback
📍

Where

1 site
Motion Analysis Lab in the Kennedy Krieger Institute
Baltimore, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy